Mid-term Outcomes of the Ross II Procedure in Infants and Young Children with Irreparable Mitral Disease
The Ross II procedure may represent a safe option for infants and young children when prosthetic valves are unavailable, despite the limited growth potential of the pulmonary autograft.
Authors
- Zheng Dou (ORCID: https://orcid.org/0000-0001-9634-9415)
- Benqing Zhang
- Rui Lü (ORCID: https://orcid.org/0000-0003-0097-5353)
- Yuze Liu
- Huaping Jiang (ORCID: https://orcid.org/0000-0002-0877-5578)
- Qiyu He
- Kai Ma (ORCID: https://orcid.org/0000-0002-0043-8710)
- Xinjie Lin (ORCID: https://orcid.org/0000-0002-0332-3505)
- Shoujun Li (ORCID: https://orcid.org/0000-0001-7943-2911)
- Ye Lin
- Keming Yang
- Yanbing Ma
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Fu Wai Hospital (CN)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1093/ejcts/ezaf359
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00